New Treatments Could Transform Care for Hidradenitis Suppurativa (HS)
A new report predicts that the market for hidradenitis suppurativa (HS) treatments will grow significantly over the next decade, from […]
Browsing category
A new report predicts that the market for hidradenitis suppurativa (HS) treatments will grow significantly over the next decade, from […]
European drug regulators have recommended rejecting Elevidys, a gene therapy for Duchenne muscular dystrophy (DMD), in a setback for its […]
Astellas and Apellis are competing for market share in the U.S. for their geographic atrophy (GA) treatments, Izervay and Syfovre. […]
The pharmaceutical industry is highly competitive, which has led to a big increase in healthcare advertising, with spending expected to […]
Earlier this year, EyePoint Pharmaceuticals faced doubts about its drug-device combo, Duravyu, after it failed in a study for nonproliferative […]
Here’s a simplified version of the text: There’s a rare heart condition known as transthyretin amyloidosis cardiomyopathy that has caught […]
In the pharmaceutical world, there’s a big competition to create the best obesity drugs, currently dominated by Novo Nordisk and […]
Here’s a simplified summary of the regulatory updates for various pharmaceutical products: 1. Pfizer’s Elrexfio: Recommended in England for multiple […]
Thorsten Stafforst recalls being discouraged from pursuing his research. In the early 2010s, scientists were excited about CRISPR, a tool […]
At a conference in New England, Rohan Simon, an associate director at the UAE’s first contract research organization, discussed the […]